The effect of testosterone replacement therapy on bladder functions, histology, apoptosis, and Rho-kinase expression in bladder outlet obstruction and hypogonadism rat model

Conclusions: The research draws attention to alternating treatment approaches in case of the presence of hypogonadism and BOO.Key words: Bladder, rho-kinase expression, hypogonadism, apoptosis, bladder outlet obstruction

📌 3 Key Takeaways

🎯

Objective & Hypothesis:Background/aim: The effect of testosterone replacement therapy was investigated on bladder functions, histology, apoptosis as well as Rho-kinase expression in the rat bladder outlet obstruction (BOO) and hypogonadism models.

📊

Key Findings & Data:Materials and methods: 30 mature male rats divided into 4 groups: sham group (n = 8), BOO group (n = 8), BOO + orchiectomy group (n = 7), BOO + orchiectomy + testosterone (T) treatment group (n = 7).

💡

Conclusion & Impact:Conclusions: The research draws attention to alternating treatment approaches in case of the presence of hypogonadism and BOO.Key words: Bladder, rho-kinase expression, hypogonadism, apoptosis, bladder outlet obstruction

🔬Design:Modeling & Simulation

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Background/aim: The effect of testosterone replacement therapy was investigated on bladder functions, histology, apoptosis as well as Rho-kinase expression in the rat bladder outlet obstruction (BOO) and hypogonadism models. Materials and methods: 30 mature male rats divided into 4 groups: sham group (n = 8), BOO group (n = 8), BOO + orchiectomy group (n = 7), BOO + orchiectomy + testosterone (T) treatment group (n = 7). Cystometric findings, apoptosis index, Rho-kinase (ROCK-2) expression, and smooth muscle/collagen ratio were compared. Results: BOO did not change ROCK-2 expression level, compared to sham group (P > 0.05). However, when compared to BOO group (P < 0.01), BOO + orchiectomy led ROCK-2 increase. The testosterone treatment failed to reverse the up-regulation of ROCK-2 induced by orchiectomy although it tended to lower ROCK-2 level. Compared to sham group (P = 0.002), changes in maximal bladder capacity and leak point pressure were higher (P = 0.026, P = 0.001), and bladder compliance was lower in BOO group. Also, the apoptosis index was different between the two groups (P = 0.380). Smooth muscle/collagen ratio was higher in BOO + orchiectomy + T group than in BOO + orchiectomy group (P = 0.010). Conclusions: The research draws attention to alternating treatment approaches in case of the presence of hypogonadism and BOO.Key words: Bladder, rho-kinase expression, hypogonadism, apoptosis, bladder outlet obstruction

🔖

Cite This Article

TİFTİK, R. N., BÜYÜKAFŞAR, K., BOZLU, M., ÇAYAN, S., ARPACI, R. B., SAYLAM, B., EFESOY, O., TEK, M. (2022). The effect of testosterone replacement therapy on bladder functions, histology, apoptosis, and Rho-kinase expression in bladder outlet obstruction and hypogonadism rat model. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 3, 1491–1499. https://ajindex.com/articles/609575

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Kim JY, Han JY, Kwon TG, Choo MS. Effects of oral Rho kinase inhibitor fasudil on detrusor overactivity after bladder outlet obstruction in rats. Lower urinary tract symptoms 2013; 5 (2): 96-100. doi: 10.1111/j.1757-5672.2012.00169.x 2. Bing W, Chang S, Hypolite JA, DiSanto ME, Zderic SA et al. Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase. American Journal of Physiology-Renal Physiology 2003; 285 (5): 990-997. doi: 10.1152/ajprenal.00378.2002 3. Andersson KE, Arner A. Urinary bladder contraction and relaxation: physiology and pathophysiology. Physiological reviews 2004; 84 (3): 935-986. doi: 10.1152/physrev.00038.2003 4. Ogut O, Brozovich FV. Regulation of force in vascular smooth muscle. Journal of molecular and cellular cardiology 2003; 35 (4): 347-355. doi: 10.1016/s0022-2828(03)00045-2 5. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. The Journal of Physiology 2000; 522 (2): 177-185. doi: 10.1111/j.1469-7793.2000.t01-2-00177.x 6. Buyukafsar K, Levent A, Ark M. Expression of Rho-kinase and its functional role in the contractile activity of the mouse vas deferens. British journal of pharmacology 2003;140 (4): 743- 749. doi: 10.1038/sj.bjp.0705479 7. Wibberley A, Chen Z, Hu E, Hieble JP, Westfall TD. Expression and functional role of Rho-kinase in rat urinary bladder smooth muscle. British Journal of Pharmacology 2003; 138 (5): 757-766. doi: 10.1038/sj.bjp.0705109 8. Meikle AW, Arver S, Dobs AS, Adolfsson J, Sanders SW et al. Prostate size in hypogonadal men treated with a nonscrotal permeation-enhanced testosterone transdermal system. Urology 1997; 49 (2): 191-196. doi: 10.1016/s0090- 4295(96)00445-1 9. Tek M, Balli E, Cimen B, Efesoy O, Oguz I et al. The effect of testosterone replacement therapy on bladder functions and histology in orchiectomized mature male rats. Urology 2010; 75 (4): 886-890. doi: 10.1016/j.urology.2009.08.016 10. Cayan S, Canpolat B, Cayan F, Yilmaz N, Kartal A et al. The effect of chronic inflammatory condition of the bladder and estrogen replacement therapy on bladder functions and histology in surgically menopause and chronic cystitis induced rats. Neurourology and Urodynamics 2006; 25 (2): 194-201. doi: 10.1002/nau.20158 11. Buyukafsar K, Akca T, Nalan Tiftik R, Sahan-Firat S, Aydin S. Contribution of Rho-kinase in human gallbladder contractions. European Journal of Pharmacology 2006; 5